Work

A chemically-modified miR-21 inhibitor (ADM-21) as a novel potential therapy in bladder cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.335

Authors: Alexandra Drakaki, Marina Koutsioumpa, Neil A. O'Brien, Christina Vorvis, Dimitrios Iliopoulos, Dennis J. Slamon

Institution: University of California, Los Angeles

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601965721

Cites:

Cited by: 5

Related to: 10